FI823356L - Dna, rekombinations-dna, dessa innehaollande vaerdar, polypeptider samt foerfaranden foer deras framstaellning - Google Patents

Dna, rekombinations-dna, dessa innehaollande vaerdar, polypeptider samt foerfaranden foer deras framstaellning

Info

Publication number
FI823356L
FI823356L FI823356A FI823356A FI823356L FI 823356 L FI823356 L FI 823356L FI 823356 A FI823356 A FI 823356A FI 823356 A FI823356 A FI 823356A FI 823356 L FI823356 L FI 823356L
Authority
FI
Finland
Prior art keywords
dna
vaerdar
polypeptider
recombinations
deras framstaellning
Prior art date
Application number
FI823356A
Other languages
English (en)
Other versions
FI80719C (fi
FI823356A0 (fi
FI80719B (fi
Inventor
Francois Meyer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27261323&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI823356(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI823356A0 publication Critical patent/FI823356A0/fi
Publication of FI823356L publication Critical patent/FI823356L/fi
Application granted granted Critical
Publication of FI80719B publication Critical patent/FI80719B/fi
Publication of FI80719C publication Critical patent/FI80719C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI823356A 1981-10-03 1982-10-01 Foerfarande foer framstaellning av maenniskointerferonpolypeptider. FI80719C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8129937 1981-10-03
GB8129937 1981-10-03
GB8208988 1982-03-26
GB8208988 1982-03-26
GB8224871 1982-09-01
GB08224871A GB2108510B (en) 1981-10-03 1982-09-01 Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Publications (4)

Publication Number Publication Date
FI823356A0 FI823356A0 (fi) 1982-10-01
FI823356L true FI823356L (fi) 1983-04-04
FI80719B FI80719B (fi) 1990-03-30
FI80719C FI80719C (fi) 1990-07-10

Family

ID=27261323

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823356A FI80719C (fi) 1981-10-03 1982-10-01 Foerfarande foer framstaellning av maenniskointerferonpolypeptider.

Country Status (19)

Country Link
US (1) US5089400A (fi)
EP (1) EP0076489B1 (fi)
JP (2) JPH06104066B2 (fi)
KR (1) KR920007665B1 (fi)
AU (1) AU561104B2 (fi)
DD (1) DD204266A5 (fi)
DE (1) DE3280174D1 (fi)
DK (1) DK170714B1 (fi)
ES (2) ES516154A0 (fi)
FI (1) FI80719C (fi)
GB (1) GB2108510B (fi)
GR (1) GR76992B (fi)
HU (1) HU197047B (fi)
IE (1) IE54051B1 (fi)
IL (1) IL66920A0 (fi)
NO (1) NO166494C (fi)
NZ (1) NZ202058A (fi)
PH (2) PH21524A (fi)
PT (1) PT75643B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
DE3220116A1 (de) 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
JPS59501866A (ja) * 1982-10-11 1984-11-08 ナショナル・リサ−チ・ディベロップメント・コ−ポレイション 腸内ウイルスに対するワクチン接種に有用なポリペプチド
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0194006B1 (en) * 1985-02-01 1992-04-29 Imperial Chemical Industries Plc Analogous interferon polypeptides, process for their preparation and pharmaceutical compositions containing them
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
ATE81675T1 (de) * 1985-04-30 1992-11-15 Takeda Chemical Industries Ltd Produktion eines proteins.
DE3685996T2 (de) * 1985-06-11 1993-01-14 Ciba Geigy Ag Hybrid-interferone.
EP0242329B1 (en) 1986-04-15 1995-07-19 Ciba-Geigy Ag Monoclonal antibodies against interferon-induced human protein in pure form, and test kits containing these antibodies
TW218846B (fi) * 1992-04-07 1994-01-11 Ciba Geigy
US6261808B1 (en) 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
US5733733A (en) * 1992-08-04 1998-03-31 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US5834202A (en) * 1992-08-04 1998-11-10 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
WO1994003624A1 (en) * 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US20020102236A1 (en) * 1994-12-08 2002-08-01 Taylor Peter William Liposomal interferon hybrid compositions
ATE207538T1 (de) 1995-02-09 2001-11-15 Behringwerke Ag Verfahren zur produktion von proteinen
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
DE19919149A1 (de) * 1999-04-27 2000-11-16 Wieser Raimund J Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere
IL155741A0 (en) 2000-11-03 2003-12-23 Pbl Biomedical Lab Interferons, uses and compositions related thereto
WO2002088161A1 (en) * 2001-05-02 2002-11-07 Pepgen Corporation Method for expression of human interferon alpha 1 in pichia pa storis
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
AU2005317574B2 (en) * 2004-12-20 2011-11-03 Cadila Healthcare Limited Process for preparing high levels of interferon beta
KR102036463B1 (ko) 2016-11-21 2019-10-24 닛토덴코 가부시키가이샤 점착 시트
KR102055078B1 (ko) 2016-11-21 2019-12-11 닛토덴코 가부시키가이샤 점착 시트

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
DK170236B1 (da) * 1980-01-08 1995-07-10 Biogen Inc Rekombinante DNA-molekyler, fremgangsmåde til fremstilling af et polypeptid af IFN-alfa typen og fremgangsmåde til udvælgelse af DNA-sekvenser, der koder for polypeptider af IFN-alfa typen
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
JP2687995B2 (ja) * 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Ｄｎａ配列、組替えｄｎａ分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Also Published As

Publication number Publication date
EP0076489A2 (de) 1983-04-13
NO823314L (no) 1983-04-05
PT75643B (en) 1986-11-13
PH21524A (en) 1987-11-16
FI80719C (fi) 1990-07-10
JPH07173195A (ja) 1995-07-11
AU8895882A (en) 1983-04-14
FI823356A0 (fi) 1982-10-01
KR840002031A (ko) 1984-06-11
DD204266A5 (de) 1983-11-23
ES528141A0 (es) 1985-11-01
AU561104B2 (en) 1987-04-30
DK437382A (da) 1983-04-04
JPS5890596A (ja) 1983-05-30
ES8601237A1 (es) 1985-11-01
GB2108510B (en) 1984-12-12
KR920007665B1 (ko) 1992-09-14
US5089400A (en) 1992-02-18
ES8504936A1 (es) 1985-04-16
FI80719B (fi) 1990-03-30
NZ202058A (en) 1986-05-09
ES516154A0 (es) 1985-04-16
PT75643A (en) 1982-11-01
IL66920A0 (en) 1982-12-31
NO166494B (no) 1991-04-22
JPH06104066B2 (ja) 1994-12-21
DE3280174D1 (de) 1990-06-21
DK170714B1 (da) 1995-12-18
IE822385L (en) 1983-04-30
EP0076489A3 (en) 1984-03-28
GB2108510A (en) 1983-05-18
NO166494C (no) 1991-08-07
PH23119A (en) 1989-05-05
GR76992B (fi) 1984-09-04
JP2612149B2 (ja) 1997-05-21
HU197047B (en) 1989-02-28
EP0076489B1 (de) 1990-05-16
IE54051B1 (en) 1989-05-24

Similar Documents

Publication Publication Date Title
FI823356A0 (fi) Dna, rekombinations-dna, dessa innehaollande vaerdar, polypeptider samt foerfaranden foer deras framstaellning
FI853046A0 (fi) Verkligtidsmonitor foer hjaertljud samt analysfoerfarande.
FI880174A0 (fi) Tertiaerae hydroxialkylxantiner, foerfarande foer deras framstaellning, dessa innehaollande laekemedel samt deras anvaendning.
FI852203A0 (fi) 7-amino-1-cyklopropyl-6, 8-dihalogen-1, 4-dihydro-4-oxo-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning samt dessa innehaollande antibakteriella aemnen.
FI853489L (fi) Foerfarande foer spjaelkning av dubbelstraengad dna.
FI820545L (fi) Arkframstaellningsfoerfarande samt genom foerfarandet framstaellt saekerhetsdokument
FI853611A0 (fi) Bloedningshaemmande proteiner, foerfarande foer framstaellning samt deras anvaendning.
FI73509B (fi) Foerfarande foer taetning av utrymmet mellan tvao i varandra inskjutbara, vaesentligen koaxiala taetningsytor samt taetningsanordning foer genomfoerande av foerfarandet.
FI863198A (fi) Korrosionsskyddskompositioner samt oljekompositioner innehaollande dessa korrosionsskyddskompositioner.
FI823497L (fi) Spelklubba, saerskilt ishockeyklubba, samt saett att framstaella denna
FI823938L (fi) N-substituerade 2-pyridylindoler, foerfarande foer deras framstaellning, dessa foereningar innehaolfarmaceutiska preparat, samt deras anvaendning
FI850916A0 (fi) Skumflotationsfoerfarande samt samlare.
FI853028L (fi) Kopplingsstycke foer distributionssystem foer uppvaermt braensle samt foerfarande.
FI823536L (fi) Vaetskeformig roek, fraon vilken tjaera avlaegsnats, samt daermed behandlat livsmedelshoelje
FI860047A0 (fi) Optiskt styrt resonanselement samt kraftmaetningsfoerfarande.
FI860399A0 (fi) Aromatiska alkanderivat, dessa foereningar innehaollande bekaempningsmedel samt foerfarande foer deras framstaellning.
FI822033A0 (fi) Imidatsolylpropionitriler, foerfarande foer framstaellning av dessa foerenigar samt biocider innehaollande dessa foereningar
FI73971B (fi) 2-halogenacetanilidfoereningar samt herbicidkompositioner innehaollande desamma.
FI843486A0 (fi) Luftkonditionerad wc-stol samt foerfarande foer framstaellning daerav.
FI860737A0 (fi) Fluorhaltiga n-sulfenylerade indazoler, foerfarande foer deras framstaellning samt deras anvaendning.
FI833421A0 (fi) Amidoglykosidderivat, foerfaranden foer deras framstaellning samt deras anvaendning
FI73972B (fi) 2-halogenacetanilidfoereningar samt herbicidkompositioner innehaollande desamma.
FI853073A0 (fi) --karbolinderivat samt foerfarande foer deras framstaellning.
FI812789L (fi) Foerfarande foer framstaellning av en plattyta, i synnerhet en keramisk plattyta samt byggnadsskivprodukt
FI840566A (fi) Doseringsfoerfarande samt daertill hoerande doseringsskopa.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed
MM Patent lapsed

Owner name: NOVARTIS AG